Big pharma is running ahead with mRNA jabs—learn what it's up to and stay ahead of the pack
MHRA is right behind it, waving through the mRNA jabs en masse...
Lipid Nano Particles (LNPs) ain’t going away
Medical freedom fighter Kjell Tore kindly sent me this (his Substack here):
So, whilst waning vaccine uptake is welcome news, they are still running ahead with all kinds of mRNA killler projects still to be released on the world.
The usual suspects, Pfizer, AstraZeneca and Moderna are in there, but look at the other companies with funny names. It’s all fantasy, of course.
All made up companies with no substance underneath…
Let’s take BioNTech as another funny name. This tells us a bit about them:
Here are the Board Memebers, all dressed in blue casuals - looking trendy:
Every Board of these funny name companies have the same Look&Feel! Have some fun, look at Autolus Leadership. Only problem is that they make up the entire company, with very few employees underneath, just a few token ‘scientists’.
…but wait, UK Government comes to the rescue, with £66 million smackeroonies to help them employ some staff and build a facility:
We can’t be complacent
The pressure has to stay on folks until all these companies are exposed and shut down!
Giving a shout out to Alison Wright and here Substack: Part 1. MHRA directors, Dr Junaid Bajwa and Amanda Calvert, due diligence. (substack.com). Multiple (illegal) identities at MHRA and beyond.
I’ll be back to this very soon, keep your eyes peeled :O)
CEPI (formed in 2016 by WEF, BMGF & Wellcome) had its sights on the "mRNA" LNP as an interchangeable switch-in/out platform. It seems self-evident that even as the experts proclaimed caution, P.-H. Lambert, D. M. Ambrosino, S. R. Andersen et al., Consensus summary report for CEPI/BC March 12–13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines, Vaccine,
"Of course, disadvantages include the novel nature of both mRNA and DNA vaccines without any licensed vaccine with either technology to date and lack of experience for mass production. Therefore, multiple platforms for SARS-CoV-2 are under development that mitigate against some of the potential disadvantages of nucleic acid vaccines."
By December 2020, the UK was mass jabbing its populace with a synthetic polynucleotide LNP brew of uncertain, unreliable composition....
Look at this „funny“ emergence use authorization stuff what I found on a deleted website https://julimination.wordpress.com/2023/11/23/emergency-use-authorization-of-covid-19-tests-independent-assessment-of-the-fdas-response/